The following anti-human monoclonal antibodies (mAbs) were used for flow cytometry:
CD3- PE-Cy7 (Beckman Coulter, USA, clone UCHT1),
CD56-APC (Beckman Coulter, USA, clone N901),
CD56-Brilliant Violet 421 (Sony, USA, clone HCD56),
CD56-PE (Beckman Coulter, USA, clone N901 (HLDA6)),
CD57-PE (eBioscience, USA, clone TB01),
CD57-FITC (Miltenyi Biotech, Germany, clone TB03),
CD57-APC (Miltenyi Biotech, Germany, TB03),
CD16-PE (Sony, USA)
anti-NKG2A-PE (R&D Systems, USA, clone 131411), anti-KIR2DL2/DL3-PE (Miltenyi Biotech, Germany, clone DX27),
anti-HLA-DR-FITC (Beckman Coulter, USA, clone B8.12.2). Cells were incubated in PBS containing 0.5% BSA (bovine serum albumin) and 0.01% sodium azide (labeling buffer) with mAbs for 30 min on ice, then washed twice with labeling buffer and centrifugation. Samples were subsequently analyzed using
FACSCalibur flow cytometer (BD Biosciences, San Jose CA, USA) equipped with 488 and 640 nm lasers. At least 30000 events were recorded in lymphocyte gate for total NK cell population and 5000 events for NK cell clones. Acquired data was analyzed using Flowing Software version 2.5.1 (PerttuTerho, Turku Centre for Biotechnology, Finland) and
FlowJo software version 7.6 (FlowJo LLC, Ashland, OR, USA). For fluorescence-activated cell sorting, cells were labeled with mAbs in PBS containing 0.5% BSA and 2 mM EDTA.
Streltsova M.A., Erokhina S.A., Kanevskiy L.M., Lee D.A., Telford W.G., Sapozhnikov A.M, & Kovalenko E.I. (2018). Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of “senescent” NK cells to lose CD57 expression and start expressing NKG2A. PLoS ONE, 13(12), e0208469.